LYNPARZA Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for LYNPARZA with the United States Patent and Trademark Office. The USPTO has given the LYNPARZA trademark a serial number of 86476170. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 20, 2026. This trademark is owned by AstraZeneca AB. The LYNPARZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology
lynparza

General Information

Serial Number86476170
Word MarkLYNPARZA
Filing DateWednesday, December 10, 2014
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 20, 2026
Registration Number4991136
Registration DateTuesday, July 5, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe word(s) "LYNPARZA" has no meaning in a foreign language.
Goods and ServicesPharmaceutical preparations and substances for use in oncology
Description of MarkThe mark consists of the word "LYNPARZA" appearing above a helix design.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 13, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Saturday, December 13, 2014NEW APPLICATION ENTERED
Saturday, December 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 16, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 14, 2015ASSIGNED TO EXAMINER
Thursday, February 19, 2015NON-FINAL ACTION WRITTEN
Thursday, February 19, 2015NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 8, 2015ASSIGNED TO LIE
Wednesday, July 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 23, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 5, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 25, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, April 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 1, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, April 12, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 5, 2016REGISTERED-PRINCIPAL REGISTER
Monday, July 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 11, 2022TEAS SECTION 8 & 15 RECEIVED
Friday, October 7, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 7, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 7, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 5, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 14, 2025TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 20, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 20, 2026REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 20, 2026REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, January 20, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

lynparza oncology substances preparations pharmaceutical